Hematologic Cancer Curricula

Browse Hematologic by...

Benign Hematology

Clinical Research

Diagnosis

  1. Procedures & Studies
  2. Signs & Symptoms

Treatment

CLL

Clinical Research

Complications / Morbidity

Diagnosis

  1. Procedures & Studies
  2. Signs & Symptoms

Epidemiology / Etiology

Screening / Prevention

Staging

  1. Prognostic Factors
  2. System

Supportive / Palliative Care

Treatment by Type

  1. Radiation Therapy
  2. Systemic- Biologic / Targeted Therapy
  3. Systemic- Bone Marrow / Stem Cell Transplant
  4. Systemic - Chemotherapy

Tumor / Molecular Biology

CML

Clinical Research

Complications / Morbidity

Diagnosis

  1. Procedures & Studies
  2. Signs & Symptoms

Epidemiology / Etiology

Screening / Prevention

Staging

  1. Prognostic Factors
  2. System

Supportive / Palliative Care

Treatment by Type

  1. Surgery
  2. Systemic- Biologic / Targeted Therapy
  3. Systemic- Bone Marrow / Stem Cell Transplant
  4. Systemic - Chemotherapy

Tumor / Molecular Biology

Hodgkin's Lymphoma

Clinical Research

Complications / Morbidity

Diagnosis

  1. Procedures & Studies
  2. Signs & Symptoms

Epidemiology / Etiology

Screening / Prevention

Staging

  1. Prognostic Factors
  2. System

Supportive / Palliative Care

Treatment By Type

  1. Radiation Therapy
  2. Systemic- Bone Marrow / Stem Cell Transplant
  3. Systemic - Chemotherapy

Tumor / Molecular Biology

Multiple Myeloma

Clinical Research

Complications / Morbidity

Diagnosis

  1. Procedures & Studies
  2. Signs & Symptoms

Epidemiology / Etiology

Screening / Prevention

Staging

  1. Prognostic Factors
  2. System

Supportive / Palliative Care

Treatment by Type

  1. Systemic- Biologic / Targeted Therapy
  2. Systemic- Bone Marrow / Stem Cell Transplant
  3. Systemic - Chemotherapy

Tumor / Molecular Biology

Myelodysplastic Disorders

Clinical Research

Complications / Morbidity

Diagnosis

  1. Procedures / Diagnosis
  2. Signs & Symptoms

Epidemiology / Etiology

Screening / Prevention

Staging

  1. Prognostic Factors
  2. System

Supportive / Palliative Care

Treatment by Type

  1. Systemic- Biologic / Targeted Therapy
  2. Systemic- Bone Marrow / Stem Cell Transplant
  3. Systemic - Chemotherapy

Tumor / Molecular Biology

Myelodysplastic Syndromes

Clinical Research

Complications / Morbidity

Diagnosis

  1. Procedures & Studies
  2. Signs & Symptoms

Epidemiology / Etiology

Screening / Prevention

Staging

  1. Prognostic Factors
  2. System

Supportive / Palliative Care

Treatment by Type

  1. Systemic- Biologic / Targeted Therapy
  2. Systemic- Bone Marrow / Stem Cell Transplant
  3. Systemic - Chemotherapy

Tumor / Molecular Biology

Non-Hodgkin's Lymphoma

Clinical Research

Complications / Morbidity

Diagnosis

  1. Procedures & Studies
  2. Signs & Symptoms

Epidemiology / Etiology

Screening / Prevention

Staging

  1. Prognostic Factors
  2. System

Supportive / Palliative Care

Treatment by Type

  1. Radiation Therapy
  2. Systemic- Biologic / Targeted Therapy
  3. Systemic- Bone Marrow / Stem Cell Transplant
  4. Systemic - Chemotherapy

Tumor / Molecular Biology

Other Leukemias

Clinical Research

Complications / Morbidity

Diagnosis

  1. Procedures & Studies
  2. Signs & Symptoms

Epidemiology / Etiology

Screening / Prevention

Staging

  1. Prognostic Factors
  2. System

Supportive / Palliative Care

Treatment by Type

  1. Systemic- Biologic / Targeted Therapy
  2. Systemic- Bone Marrow / Stem Cell Transplant
  3. Systemic - Chemotherapy

Tumor / Molecular Biology

Educational Grants

The Online Hematologic Cancer Core Curriculum is supported by an educational grant from:

GlaxoSmithKline

Bristol-Myers Squibb

News Updates | Journal Watch Updates

Conference Name Date(s) Location
T-Cell and B-Cell Non-Hodgkin Lymphoma Revisited: Therapeutic Paradigms and Advances Dec 5, 2008 San Francisco, CA
Critical Advances in the Management of Immune Thrombocytopenic Purpura Dec 5, 2008 San Francisco, CA
Rapid Reviews in Oncology: Practice-Changing Developments in Hematologic Malignancies Dec 11, 2008 Multiple Locations Nationwide
Current Trends in Leukemia, Lymphoma, and Myeloma Jan 10, 2009 Dallas, TX
Current Trends in Leukemia, Lymphoma, and Myeloma Jan 10, 2009 San Francisco, CA
Current Trends in Leukemia, Lymphoma, and Myeloma Jan 16, 2009 Chicago, IL
Current Trends in the Treatment of Haematologic Malignancies Jan 17, 2009 Istanbul, Turkey
Current Trends in Leukemia, Lymphoma, and Myeloma Jan 24, 2009 New York, NY
Current Trends in Leukemia, Lymphoma, and Myeloma Jan 24, 2009 Kansas City, MO
Current Trends in Leukemia, Lymphoma, and Myeloma Jan 31, 2009 Washington, DC
Current Trends in Leukemia, Lymphoma, and Myeloma Jan 31, 2009 White Plains, NY
Current Trends in Leukemia, Lymphoma, and Myeloma Feb 7, 2009 Seattle, WA
13th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myelomas Feb 11-15, 2009 Whistler, British Columbia, Canada
Current Trends in Leukemia, Lymphoma, and Myeloma Feb 21, 2009 Philadelphia, PA
Current Trends in Leukemia, Lymphoma, and Myeloma Feb 28, 2009 San Juan, Puerto Rico
Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies Mar 19-20, 2009 Orlando, FL
Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies Apr 24-25, 2009 Asheville, NC